Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Affinity DataIC50: 0.400nMpH: 7.2 T: 2°CAssay Description:pH dependent Ca2+ responses in TRPV1/CHO cells cultured in a 96-well plate were determined (see, e.g., FIG. 2 of U.S. Patent Application Publication ...More data for this Ligand-Target Pair
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Affinity DataIC50: 0.400nMpH: 7.2 T: 2°CAssay Description:pH dependent Ca2+ responses in TRPV1/CHO cells cultured in a 96-well plate were determined (see, e.g., FIG. 2 of U.S. Patent Application Publication ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Affinity DataIC50: 0.5nMpH: 7.4Assay Description:Two days prior to performing this assay, cells are seeded on poly-D-lysine-coated 96-well clear-bottom black plates (commercially available from Bect...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Purdue Pharma L.P.; Shionogi & Co., Ltd.
US Patent
Affinity DataIC50: 0.600nMpH: 7.2 T: 2°CAssay Description:pH dependent Ca2+ responses in TRPV1/CHO cells cultured in a 96-well plate were determined (see, e.g., FIG. 2 of U.S. Patent Application Publication ...More data for this Ligand-Target Pair
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
Ligand Info
In DepthDetails
![](/img/powered_by_small.gif)